Joining the Fight Against Glioblastoma
Daniel W. Offit died in 2021 from Glioblastoma (GBM), the most common and deadliest form of adult brain cancer. To date there has been little progress made in identifying a cure for this disease, with the average life expectancy after diagnosis being around 14 months.
With guidance from our Scientific Advisory Board, we will allocate every dollar that we raise in Dan's memory to fund research and therapies that have the most viable path to a cure for Glioblastoma.
Honoring a Legacy
Dan was revered by his family, friends, work colleagues, and within the educational institutions he led and supported. Dan’s legacy is his unwavering moral compass, inspiring leadership, resilience, kind heart, and sense of humor. Despite having lost his own fight, we know that he would want us to continue harnessing the deep network of relationships that were formed throughout his treatment, with the ultimate goal of curing Glioblastoma.
Scientific Advisory Board
Our Scientific Advisory Board has leaders from the fields of Neuro-Oncology, Immunotherapy, and Life Sciences Investing. Their expertise ensures that our resources are strategically allocated to initiatives with the highest potential to significantly impact the battle against glioblastoma.
Partnering for Progress
Connect with us today to learn more about how you can help honor Dan's legacy by contributing to the fight against glioblastoma